Brendon J Coventry
Overview
Explore the profile of Brendon J Coventry including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
52
Citations
1553
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Wauchope B, Coventry B, Roder D
Cancers (Basel)
. 2023 Feb;
15(4).
PMID: 36831482
Even though clinically small 'early' cancers represent many millions of cells biologically, when removed surgically, these often never recur or regrow, nor reduce the individual's lifespan. However, some early cancers...
2.
Otasowie C, Tanner R, Ray D, Austyn J, Coventry B
Front Immunol
. 2022 Oct;
13:977525.
PMID: 36275731
Vaccination, as a public health measure, offers effective protection of populations against infectious diseases. Optimising vaccination efficacy, particularly for higher-risk individuals, like the elderly whose immunocompromised state can prevent the...
3.
You W, Henneberg R, Coventry B, Henneberg M
AIMS Public Health
. 2022 May;
9(2):378-402.
PMID: 35634021
Current public health advice is that high ultraviolet radiation (UVR) exposure is the primary cause of Malignant Melanoma of skin (CMM), however, despite the use of sun-blocking products incidence of...
4.
Coventry B, Ashdown M, Henneberg M, Davies P
F1000Res
. 2021 Feb;
4:552.
PMID: 33365125
This review explores the incessant evolutionary interaction and co-development between immune system evolution and somatic evolution, to put it into context with the short, over 60-year, detailed human study of...
5.
Carr M, Sun J, Kroon H, Miura J, Beasley G, Farrow N, et al.
Ann Surg Oncol
. 2020 Sep;
27(13):5107-5118.
PMID: 32918177
Background: Isolated limb infusion (ILI) is a minimally invasive procedure for delivering high-dose chemotherapy to extremities affected by locally advanced or in-transit melanoma. This study compared the outcomes of melanoma...
6.
Kenyon-Smith T, Kroon H, Miura J, Teras J, Beasley G, Mullen D, et al.
Eur J Surg Oncol
. 2020 Aug;
46(11):2140-2146.
PMID: 32739218
Introduction: Isolated limb infusion (ILI) is a minimally-invasive procedure for delivering high-dose regional chemotherapy to treat melanoma in-transit metastases confined to a limb. The aim of this international multi-centre study...
7.
Teras J, Kroon H, Miura J, Kenyon-Smith T, Beasley G, Mullen D, et al.
Ann Surg Oncol
. 2020 Mar;
27(5):1420-1429.
PMID: 32152775
Background: Isolated limb infusion (ILI) is used to treat in-transit melanoma metastases confined to an extremity. However, little is known about its safety and efficacy in octogenarians and nonagenarians (ON)....
8.
Uppal A, Stern S, Thompson J, Foshag L, Mizzollo N, Nieweg O, et al.
Ann Surg Oncol
. 2019 Dec;
27(6):1970-1977.
PMID: 31863416
Background: Recommended treatment for patients with sentinel lymph node (SLN)-positive melanoma has recently changed. Randomized trials demonstrated equivalent survival with close observation versus completion lymph node dissection (CLND), but increased...
9.
Coventry B
Ther Adv Vaccines Immunother
. 2019 Aug;
7:2515135519862234.
PMID: 31414074
Recent immunotherapy advances have convincingly demonstrated complete tumour removal with long-term survival. These impressive clinical responses have rekindled enthusiasm towards immunotherapy and tumour antigen vaccination providing 'cures' for melanoma and...
10.
Scolyer R, Soyer H, Kelly J, James C, McLean C, Coventry B, et al.
Aust J Gen Pract
. 2019 Jun;
48(6):357-362.
PMID: 31220881
Background: Incorrect or delayed diagnosis of melanoma may lead to inappropriate treatment, poor clinical outcomes, increased cost and medicolegal consequences. The provision of pertinent clinical information is essential for accurate...